Daiichi Sankyo Nordics ApS - Sweden Filial

Nobuya Ikeda

Corporate Officer, Head of R&D Planning & Management Function, R&D Division

Kenji Shigeta

Corporate Officer, Head of Global Oncology Marketing, Oncology Business Unit

Paul Diolosa

Head of American Regent Unit

Mitsuhiro Matsumoto

Outside Audit & Supervisory Board Member (Independent Auditor)

Shizuko Ueno

Director, Executive Officer, Head of Japan Business Unit and Head of Medical Affairs Division, Japan Business Unit

Naoki Shimizu

Head of Global QA, Chief Quality Officer (CQO)

Yo Honma

Outside Director (Independent Director), Chairperson of the Compensation Committee

Yukiko Imazu

Outside Audit & Supervisory Board Member (Independent Auditor)

Kentaro Asakura

Corporate Officer, Head of Corporate Communications Department, Global Corporate Planning & Management

Koichi Nonaka

Corporate Officer, Head of Technology Development Supervisory Department, Technology Division

Reiko Kinoshita

Outside Director (Independent Director)

Kento Wada

Head of Clinical Safety & Pharmacovigilance Unit

Junichi Ashihara

Corporate Officer, Head of Japan Plant Management Supervisory Department, Technology Division

Hiroto Kashiwase

Head of Technology Unit

Tetsuya Iwabuchi

Corporate Officer, In charge of Business Development

Takaaki Nishii

Outside Director (Independent Director), Chairperson of the Board

Manabu Murata

Head of Global Internal Audit

James Felix

Head of Global DX, Chief Digital Transformation Officer (CDXO)

Hanako Saito

Corporate Officer, In charge of QA and CSPV

Takashi Matsumoto

Director, Senior Executive Officer, Head of Global HR, CHRO

Oliver Appelhans

Head of EU Specialty Business Unit

Tetsuya Ohira

Corporate Officer, Head of Corporate Planning Department, Global Corporate Planning & Management

Stuart Mackey

Head of Global Business Development

Hiroshi Masumoto

Executive Officer, Head of Data Intelligence Department, Global DX

Koji Ogawa

Head of Global Corporate Planning & Management, Chief Financial Officer (CFO)

Atsushi Tsukamoto

Corporate Officer, Head of Corporate Strategy & Business Portfolio Department, Global Corporate Strategy

Naoto Tsukaguchi

Head of Global Legal & IP, General Counsel (GC)

Hiroya Senda

Corporate Officer, Head of Sales & Marketing Division, Japan Business Unit

Akihiro Tokumoto

Corporate Officer, Head of Human Resources Department, Global HR

Koji Sato

Corporate Officer, Head of Technology Division and Head of Technology Planning Supervisory Department, Technology Division

Chikara Yoshida

Head of Global Government Affairs

Yasuhiro Komatsu

Outside Director (Independent Director)

Tomohiro Kodama

Corporate Officer, Head of Finance & Accounting Department, Global Corporate Planning & Management

Hideaki Noji

Corporate Officer, Head of Business Management Department, Japan Business Unit

Ken Takeshita

Head of Research & Development Unit

Hiroyuki Okuzawa

Representative Director, President & CEO

Yuki Abe

Corporate Officer, Head of R&D division and Head of Research Function, R&D Division

Terumichi Yokoyama

Audit & Supervisory Board Member

Sunao Manabe

Representative Director, Executive Chairperson

Masako Watanabe

Outside Audit & Supervisory Board Member (Independent Auditor)

Nobuo Murakami

Head of Global Corporate Strategy, Chief Strategy Officer (CStO)

Takahiro Uchida

Head of Daiichi Sankyo Healthcare Unit

Miyuki Arai

Audit & Supervisory Board Member

Joseph Kenneth Keller

Director, Head of Oncology Business Unit

Chiaki Matsumoto

Corporate Officer, Head of Regulatory Affairs Strategy Department, Development Function, R&D Division

Toshi Kajiro

Corporate Officer, Head of Compliance Strategy and Excellence, Global Compliance & Risk Management

Satoru Ogawa

Corporate Officer, Head of Secretariat Department

Akio Sakurai

Corporate Officer, Special Assignment on Japan Business

Kiminori Nagao

Head of ASCA Business Unit

Akihiro Watanabe

Outside Director (Independent Director), Chairperson of the Nomination Committee

Akihiro Inoguchi

Corporate Officer, Head of Development Function, R&D Division

Matt Allegrucci

Head of Global Compliance & Risk Management, Chief Compliance Officer (CCO)